Wall Street pounds shares of Volcano Corp. after the medical device company lowers its 2013 guidance following its 4th quarter earnings release.
Shares of Volcano (NSDQ:VOLC) were down nearly 10% on Wall Street in late-day trading Friday, after the medical device company revised its sales and earnings guidance downwards, a day after a tough 4th-quarter earnings release.
The San Diego, Calif.-based firm said it expects to turn 8¢-11¢ earnings per share on $406 million-$412 million in sales, far below the 29¢ EPS on $423.5 million analysts were projecting based on Volcano's Q4 earnings release.
Volcano did not give any reason reason for the revision in a regulatory filing.
Several Investment houses downgraded VOLC stock based on the revised guidance, including Goldman Sachs, which changed its rating from "conviction buy" to "neutral."
"We see Volcano as a 'show me' story, having missed sales 3 of the last 4 quarters and guiding below Street 3 consecutive times. Further, there are limited clinical/regulatory catalysts to drive an outer year inflection point," the bank wrote in a note to investors last week.
On Thursday, Volcano officials reported profits of $2.5 million, o 5¢ earnings per share, on $102 million in sales during the 3 months ended Dec. 31, 2012, down significantly from $29.4 million, or 56¢ EPS, on $92.7 million in sales during the same period in 2011.
For the full year, Volcano's earnings plunged to $8 million, or 15¢ EPS, on $382 million in sales, for a profit decline of some 79% compared with 2011.
VOLC shares closed down 8.3% Feb. 22 at $22.63 apiece.
Manny Villafana, who founded St. Jude Medical and Kips Bay Medical, joins a last-gasp, $3 million...
Johnson & Johnson inks a deal with Google to develop a robot-assisted surgery device.
Cardica says it will lay off about 24% of its workforce in a bid to conserve cash as it tries to get...
ReWalk Robotics plans to launch its wearable robotic exoskeleton device in India by the 2nd quarter...
Royal Philips wins another year on its $77 million contract with the U.S. Defense Dept. for patient...